Accu-Break Pharmaceuticals

About:

Accu-Break develops pharmaceutical tablet technologies to create tablets that can be easily divided by hand into exact smaller doses.

Website: http://accubreakpharmaceuticals.com

Top Investors: Institutional Investor, Pequot Capital, S.A.C Capital Associates

Description:

ACCU-BREAK Pharmaceuticals, Inc. develops and licenses pharmaceutical tablet technologies. The company offers bi-layer and tri-layer technologies, which are used to create tablets that are dividable by hand into accurate partial/smaller doses for patients to adjust their dose. Its technologies are used for single drug products, fixed and split combination drug products, standard and controlled release formulations, and incompatible drugs in human and veterinary medicines. The company has a strategic alliance agreement with Azopharma Development Group. ACCU-BREAK Pharmaceuticals, Inc. was formerly known as SoLapharm, Inc. and changed its name to ACCU-BREAK Pharmaceuticals, Inc.